Synthesis and antiviral activities of adamantane spiro compounds. 1. Adamantane and analogous spiro-3'-pyrrolidines.
D000547:Amantadine / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D001952:Bridged-Ring Compounds / Q000138:chemical synthesis; D004770:Enterovirus / Q000187:drug effects; D051379:Mice; D008815:Mice, Inbred Strains; D008826:Microbial Sensitivity Tests; D009975:Orthomyxoviridae / Q000187:drug effects; D009976:Orthomyxoviridae Infections / Q000188:drug therapy; D010222:Parainfluenza Virus 1, Human / Q000187:drug effects; D011759:Pyrrolidines / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D012229:Rhinovirus / Q000187:drug effects; D013141:Spiro Compounds / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use
D000998:Antiviral Agents; D001952:Bridged-Ring Compounds; D011759:Pyrrolidines; D013141:Spiro Compounds; D000547:Amantadine